The effects of vitamin K1 and synthetic substitutes on tumour cell sulphydryl levels.
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism*; D010954:Plasmacytoma / Q000188:drug therapy / Q000378:metabolism; D012509:Sarcoma / Q000188:drug therapy / Q000378:metabolism; D012878:Skin Neoplasms / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D013997:Time Factors; D010837:Vitamin K 1 / Q000627:therapeutic use*
D013438:Sulfhydryl Compounds; D010837:Vitamin K 1